Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies

Head & Neck, 05/02/2012

Chemoradiotherapy (CRT) for salivary gland malignancies has acceptable toxicity, CRT is proven beneficial for many other cancers, and some salivary gland malignancies are clinically responsive to chemotherapy. CRT, therefore, should be considered for treatment of high–risk salivary gland malignancies.

Print Article Summary Cat 2 CME Report